The Leptos therapy is not approved for sale in the United States, or any other country, and is limited to investigational use. We have received approval from the Food and Drug Administration (FDA) to conduct a limited feasibility investigation under an Investigational Device Exemption (IDE).

If you would like to receive further information about possible future clinical trials of the Leptos therapy, please register below.